Stem-cell funding still mired in courts
By Steve Johnson,
San Jose Mercury News
| 11. 30. 2005
JUDGE RULES SUITS ON PROPOSITION 71 CAN GO TO TRIAL
By Steve Johnson
Mercury News
A judge Tuesday denied a motion to dismiss two lawsuits challenging the legality of California's year-old $3 billion stem-cell institute, making it likely public funding for the institute will continue to be blocked well into next year.
Alameda County Superior Court Judge Bonnie Sabraw also denied motions by the plaintiffs, who had asked her to declare the stem-cell program unconstitutional.
Sabraw ordered the parties back to court Tuesday to set a trial date, noting that she planned to ``proceed to trial promptly.'' Both sides in the case said it's possible a trial might not begin until spring. Whoever loses at that point is expected to file an appeal, dragging the case out even longer.
Even so, Robert Klein, who chairs the California Institute for Regenerative Medicine, said he was happy with the judge's ruling because it found no immediate reason to declare the stem-cell program unconstitutional.
``We would have loved to have a home run,'' by having the suits dismissed, Klein said. ``But boy, this...
Related Articles
By Carl Zimmer and Marco Hernandez , The New York Times | 07.01.2026
Scientists have long dreamed of discovering the alchemy by which chemicals can be turned into life. On Wednesday, a team at the University of Minnesota announced that it had taken a major step toward that vision.
Blending together dozens of...
By Marisa Flook , BioNews | 06.29.2026
An anti-ageing gene therapy not approved by the US Food and Drug Administration (FDA) is set to be offered by an American company at overseas clinics outside of US jurisdiction.
The treatment, developed by Minicircle from Austin, Texas, uses a...
By Ed Pilkington, The Guardian | 06.12.2026
Desperate US parents paying up to $20,000 a session for a procedure scientists say could be bogus
Autistic children as young as 18 months old are being injected with human stem cells derived from umbilical cords in unapproved, unproven and...
By Tobi Thomas, The Guardian | 06.10.2026
The UK’s stem cell transplant system is potentially putting the lives of blood cancer patients at risk as a result of inadequate infrastructure and a lack of long-term planning, a parliamentary report has found.
A hematopoietic stem cell transplant, often...
